Strategies to improve non-viral vectors – potential applications in clinical transplantation

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.6, Iss.6, 2006-06, pp. : 619-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors

By Terenzi Fulvia deVeer Michael J. Ying Han Restifo Nicholas P. Williams Bryan R. G. Silverman Robert H.

Nucleic Acids Research, Vol. 27, Iss. 22, 1999-10 ,pp. : 4369-4375

Oxford University Press

Access to resources Recommend Favorite

Alphavirus vectors: development and potential therapeutic applications

By Schlesinger S.

Expert Opinion on Biological Therapy, Vol. 1, Iss. 2, 2001-03 ,pp. : 177-191

Informa Healthcare

Access to resources Recommend Favorite

Non-viral gene delivery: from the needle to the nucleus

By Rettig Garrett R Rice Kevin G

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 799-808

Informa Healthcare

Access to resources Recommend Favorite

Non-viral gene transfer therapy for cystic fibrosis

By Ziady Assem G Davis Pamela B Konstan Michael W

Expert Opinion on Biological Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Non-viral delivery of ribozymes for cancer gene therapy

By Kashani-Sabet Mohammed

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1749-1755

Informa Healthcare

Access to resources Recommend Favorite